Partial
Partially Aligned
Patient Risk:
Low
Summary
AI response partially aligns with the prescribing information. It correctly identifies that cefoxitin is an injectable antibiotic and a cephalosporin with activity described in the microbiology section. However, it makes claims about indications and supplier variations that are not supported by the provided label excerpts, and it omits critical on-label details such as actual Indications/Usage content.
Category Scores
Accurate Statements
Cefoxitin is an injectable antibiotic.
Supported by 3 DOSAGE FORMS AND STRENGTHS; 16 HOW SUPPLIED/STORAGE AND HANDLING
Cefoxitin is a cephalosporin.
Supported by 12.4 Microbiology
Unsupported Statements
Cefoxitin is older.
Label does not define age/approval date.
Cefoxitin is used for bacterial infections.
Indications/Usage not provided in the given label sections.
The company that makes a specific cefoxitin brand can vary by country.
Not addressed in the provided label sections.
The exact supplier for your local market may not be Fresenius Kabi.
Not addressed in the provided label sections.
Contradictions
Important Omissions
Indications and usage details; contraindications; adverse reactions; drug interactions; use in specific populations.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
No direct patient harm identified from on-label statements; unsupported claims could mislead.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
Yes |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Partially Aligned
Primary Issue
Several claims about Indications and supplier information are not supported by the provided label sections.
Suggested Improvement
Limit claims to what's in the label; clearly separate on-label from off-label information; cite Indication and Supplier details from the appropriate sections.